LOTUS PHARMACEUTICAL monthly revenue
LOTUS PHARMACEUTICAL LTD
| Period | Released | Revenue (NT$) | MoM % | YoY % | YTD Rev (NT$) |
|---|---|---|---|---|---|
| Jun 2026 | Jul 15, 2026 | NT$3.4B | +46.2% | +225.5% | NT$17.5B |
| May 2026 | Jun 17, 2026 | NT$2.3B | -24.7% | +105.8% | NT$14.1B |
| Apr 2026 | May 17, 2026 | NT$3.1B | -29.1% | +19.9% | NT$11.7B |
| Mar 2026 | Apr 17, 2026 | NT$4.4B | +94.5% | +173.6% | NT$8.6B |
| Feb 2026 | Mar 17, 2026 | NT$2.2B | +9.1% | +131.5% | NT$4.3B |
| Jan 2026 | — | NT$2.1B | — | -5.5% | NT$2.1B |
| Dec 2025 | — | NT$2.4B | — | +66.9% | NT$20.5B |
| Nov 2025 | — | NT$1.1B | — | -0.2% | NT$18.1B |
| Oct 2025 | — | NT$2.8B | — | +46.0% | NT$17B |
| Sep 2025 | — | NT$1.2B | — | +2.2% | NT$14.2B |
| Aug 2025 | — | NT$1.2B | — | -12.5% | NT$13B |
| Jul 2025 | — | NT$2.4B | — | -11.9% | NT$11.9B |
| Jun 2025 | — | NT$1B | — | -6.3% | NT$9.5B |
| May 2025 | — | NT$1.1B | — | -27.3% | NT$8.4B |
| Apr 2025 | — | NT$2.6B | — | +23.9% | NT$7.3B |
| Mar 2025 | — | NT$1.6B | — | +38.4% | NT$4.7B |
| Feb 2025 | — | NT$1B | — | -8.1% | NT$3.1B |
| Jan 2025 | — | NT$2.2B | — | +8.8% | NT$2.2B |
| Dec 2024 | — | NT$1.5B | — | +6.6% | NT$18.6B |
| Nov 2024 | — | NT$1.1B | — | -6.5% | NT$17.1B |
| Oct 2024 | — | NT$1.9B | — | +106.8% | NT$16.1B |
| Sep 2024 | — | NT$1.2B | — | +7.8% | NT$14.2B |
| Aug 2024 | — | NT$1.3B | — | +11.9% | NT$13B |
| Jul 2024 | — | NT$2.7B | — | +19.0% | NT$11.7B |
Values are shown in billions of TWD. Latest period: Jun 2026. Updated 2026-07-09. Source: Taiwan public company filings
Monthly Sales is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.